Financials
- Market Capitalization 1.86 B
- Employee 291
- Founded 2004
- CEO N/A
- Website www.urogen.com
- Headquarter Israel
- FIGI N/A
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-7.34
売上高対価格比率
11.93
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 1979 | XERS Xeris Biopharma Holdings, Inc. - Common Stock | 10.43 USD | -0.29% | +1.86% | +37.42% | +30.87% | 1.90 B USD | ||
| 1988 | VIR Vir Biotechnology, Inc. - Common Stock | 11.05 USD | -2.21% | -5.15% | +2.98% | +84.78% | 1.87 B USD | ||
| 2007 | MESO Mesoblast Limited - American Depositary Shares | 14.11 USD | -1.12% | +2.32% | -6.99% | -20.69% | 1.83 B USD | ||
| 2014 | XNCR Xencor, Inc. - Common Stock | 24.52 USD | -2.08% | -2.54% | -0.77% | +75.77% | 1.82 B USD |